At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 35 enrolled
Drug / intervention
Radiosurgeryradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Single Dose Partial Breast Radiotherapy Using Extra-cranial Radiosurgery in Patients With Early Stage Breast Cancer - a Phase I Dose Escalation Study
In Brief
A Phase 1 clinical trial evaluating Radiosurgery for Breast Cancer. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This study seeks to determine the maximum tolerated dose of a single-dose partial breast radiation given before lumpectomy using a radiosurgery technique. Lumpectomy will be performed within 3 weeks (+/- 1 week) of completing radiation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 2009
Enrollment StartJul 2010
Primary CompletionApr 2016
Study CompletionMar 2023
TodayJul 2026
First PostedJul 23, 2009
Enrollment StartJul 28, 2010
Primary CompletionApr 4, 2016
Study CompletionMar 25, 2023
TodayJul 2, 2026
Enrollment to primary: 5.7 yearsPosted 16.9 years ago
Interventions
Radiosurgeryradiation
Single dose or radiation in 15Gy, 18Gy or 21Gy